AAF
TARO

Andra AP-fonden’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Andra AP-fonden’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,000
Closed -$3.04M – 682
2017
Q3 		$3.04M Sell
27,000
-42,100
-61% -$4.58M 0.07% 433
2017
Q2 		$7.74M Sell
69,100
-13,100
-16% -$1.48M 0.19% 146
2017
Q1 		$9.59K Buy
82,200
+43,000
+110% +$4.76M 0.22% 112
2016
Q4 		$4.13M Buy
+39,200
New +$4.11M 0.11% 288
2016
Q3 		– Sell
-31,500
Closed -$4.59M – 644
2016
Q2 		$4.59M Buy
31,500
+6,400
+25% +$908K 0.12% 249
2016
Q1 		$3.6M Buy
+25,100
New +$3.57M 0.09% 322

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Andra AP-fonden's TARO Position: Q4 2017 in Review

Andra AP-fonden sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 27,000 shares — an estimated $3.04M sold.

Andra AP-fonden first reported a position in TARO in Q1 2016 and held it in 6 quarters. The position peaked at $7.74M in Q2 2017. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

  • Andra AP-fonden reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
  • Andra AP-fonden sold 27,000 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $3.04M.
  • Andra AP-fonden first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 6 quarters.
  • Andra AP-fonden's Taro Pharmaceutical Industries Ltd. position peaked at $7.74M in Q2 2017.
  • 127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Andra AP-fonden's 13F filing for Q4 2017, filed 14 Feb 2018.